Breaking News

PCI Pharma Services to Acquire Ajinomoto Althea

Acquisition creates a large-scale manufacturing hub in the San Diego region with aseptic facilities for prefilled syringes, cartridges and high potent formulations.

Author Image

By: Charlie Sternberg

Associate Editor

PCI Pharma Services, a global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies, is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co. Inc. Scheduled for completion in May 2025, the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges, including isolator technology for thes...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters